Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Correction: Testing and treatment for malaria elimination: a systematic review.
Newby, G; Cotter, C; Roh, ME; Harvard, K; Bennett, A; Hwang, J; Chitnis, N; Fine, S; Stresman, G; Chen, I; GOSLING, R; Hsiang, MS;
2024
Malaria journal, (2024).23 1 10.1186/s12936-024-04861-x.
Malaria elimination and the need for intensive inter-country cooperation. a critical evaluation of regional technical co-operation in Southern Africa.
Sikaala, CH; Dlamini, B; Lungu, A; Fakudze, P; Chisenga, M; Siame, CL; Mwendera, N; Shaba, D; Chimumbwa, JM; KLEINSCHMIDT, I;
2024
Malaria journal, (2024).23 1 10.1186/s12936-024-04891-5.
Efficacy of chlorfenapyr-pyrethroid and piperonyl butoxide-pyrethroid long-lasting insecticidal nets (LLINs) compared to pyrethroid-only LLINs for malaria control in Côte d'Ivoire: a three group, cluster randomised trial.
SIH, C; Protopopoff, N; Koffi, AA; Ahoua Alou, LP; Dangbenon, E; MESSENGER, LA; Kulkarni, MA; Zoh, MG; Camara, S; Assi, SB; N'GUESSAN, R; COOK, J;
2024
Trials, (2024).25 1 10.1186/s13063-024-07969-2.
Integration of the RTS,S/AS01 malaria vaccine into the Essential Programme on Immunisation in western Kenya: a qualitative longitudinal study from the health system perspective.
Hill, J; Bange, T; Hoyt, J; Kariuki, S; Jalloh, MF; WEBSTER, J; Okello, G;
2024
The Lancet. Global health, (2024).12 4 10.1016/S2214-109X(24)00013-5.
Estimation of trajectory of protective efficacy in infectious disease prevention trials using recurrent event times.
Cheung, YB; Ma, X; Lam, KF; Yung, CF; MILLIGAN, P;
2024
Statistics in medicine, (2024).43 9 10.1002/sim.10049.
Characterization of merozoite-specific thrombospondin-related anonymous protein (MTRAP) in Plasmodium vivax and P. knowlesi parasites.
Sy Thau, N; Nguyen, T-K; Truong, NV; Chu, T-TH; Na, S-H; MOON, RW; Lau, YL; Nyunt, MH; Park, W-S; Chun, W-J; Lu, F; Lee, S-K; Han, J-H; Han, E-T;
2024
Frontiers in cellular and infection microbiology, (2024).14, 10.3389/fcimb.2024.1354880.
Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial.
Kositz, C; VASILEVA, H; MOHAMMED, N; Achan, J; Dabira, ED; D'ALESSANDRO, U; BRADLEY, J; MARKS, M;
2024
Malaria journal, (2024).23 1 10.1186/s12936-024-04878-2.
Effectiveness of pyriproxyfen-pyrethroid and chlorfenapyr-pyrethroid long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs for malaria control in the third year post-distribution: a secondary analysis of a cluster-randomised contro...
Accrombessi, M; COOK, J; Dangbenon, E; SOVI, A; Yovogan, B; Assongba, L; Adoha, CJ; Akinro, B; Affoukou, C; Padonou, GG; KLEINSCHMIDT, I; MESSENGER, LA; ROWLAND, M; NGUFOR, C; Akogbeto, MC; Protopopoff, N;
2024
The Lancet. Infectious diseases, (2024).24 6 10.1016/S1473-3099(24)00002-1.
Dataset: NECTAR3 Randomized Controlled Trial.
DRAKELEY, C; Dicko, A; Bousema, T;
2024
, ClinEpiDB (2024).
Dataset: NECTAR2 Randomized Controlled Trial.
DRAKELEY, C; Dicko, A; Bousema, T;
2024
, ClinEpiDB (2024).